Can a cream regrow hair lost to frontal fibrosing alopecia?

NCT ID NCT07671157

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This Phase 2 trial tests a cream called delgocitinib in 30 adults with frontal fibrosing alopecia, a condition that causes hair loss at the front of the scalp. Everyone in the study will use the cream for 24 weeks. Researchers will measure changes in hairline and hair counts to see if the treatment helps.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

delgocitinib cream

What this could lead to

If it works, this could point toward a topical treatment to slow or reverse hair loss in frontal fibrosing alopecia.

What could go wrong

This is a small, early-phase trial with no placebo group, so results may not be conclusive. The drug may not improve hair growth or could cause skin irritation.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FRONTAL FIBROSING ALOPECIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

alopecia frontal fibrosing alopecia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Lahey Clinic

    Burlington, Massachusetts, 01805, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••